180 Life Sciences (ATNF) - 2019 Q3 - Quarterly Report
ATNF180 Life Sciences (ATNF)2019-11-13 06:05

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | |---------------------------------------- ...